The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer. Read More
Check Also
“This Shouldn’t Be a Thing Anymore” – 160+ Measles Cases Across U.S. Spark Public Health Alarm
Over 160 measles cases in 2024 have raised alarms about vaccine hesitancy and declining immunity, …